Current treatment status-Did not start treatment yet - Page 22 of 37 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Does reducing etanercept maintain remission in early rheumatoid arthritis?

Does reducing etanercept maintain remission in early rheumatoid arthritis?

Posted by on Mar 28, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the effects of reducing and withdrawing treatment in rheumatoid arthritis (RA) patients who had achieved remission using etanercept (Enbrel) plus methotrexate (Trexall). The results showed that etanercept and methotrexate (MTX) combined led to better disease control than MTX alone, or a placebo (a substance...

Read More

Predicting response to chemotherapy in advanced prostate cancer – what can genes tell us?

Predicting response to chemotherapy in advanced prostate cancer – what can genes tell us?

Posted by on Mar 21, 2016 in Prostate cancer | 0 comments

In a nutshell This study investigated the presence of the gene TMPRSS2-ERG in patients with metastatic castration-resistant prostate cancer on treatment outcome with taxane-based chemotherapy. Researchers reported that TMPRSS2-ERG, as identified by blood tests, is a reliable predictors of treatment success with taxane-based chemotherapy. Some...

Read More

Combination treatment with nivolumab and ipilimumab in untreated advanced melanoma

Combination treatment with nivolumab and ipilimumab in untreated advanced melanoma

Posted by on Mar 14, 2016 in Melanoma | 0 comments

In a nutshell The authors evaluated the effect of nivolumab (Opdivo) or ipilimumab (Yervoy) alone, or in combination in advanced melanoma. The authors found out that the combination therapy was more effective than treatment with either of the single drugs.  Some background In advanced melanoma (stages 3 and 4), cancer spreads from the skin to...

Read More

Slowing cancer progression before chemotherapy

Slowing cancer progression before chemotherapy

Posted by on Jan 28, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of enzalutamide (Xtandi) in treating patients with advanced prostate cancer requiring chemotherapy. Researchers concluded that enzalutamide treatment results in delayed disease progression and increased overall survival. Some background Hormone therapy is commonly used to treat prostate cancer. By...

Read More

The effect of prostate and lymph node surgery on erectile and bladder control

Posted by on Dec 28, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine erectile dysfunction and incontinence issues in patients following prostate surgery. Some background Prostate surgery is a common treatment used in prostate cancer. It involves surgical removal of the prostate gland. There are numerous types of prostate surgery. Nerve-sparing surgery aims to remove the...

Read More

Cancer cells left behind: Rates of positive margins following different types of prostate surgery

Cancer cells left behind: Rates of positive margins following different types of prostate surgery

Posted by on Dec 7, 2015 in Prostate cancer | 0 comments

In a nutshell This study examined the rates of positive surgical margins in both robot-assisted and open prostate removal surgeries. Some background Prostate cancer patients are often treated with radical prostatectomy (surgical removal of the prostate gland). In the standard, open approach an incision is made in the lower abdomen. In the...

Read More

A comparison of drug regimens for patients with advanced colorectal cancer

A comparison of drug regimens for patients with advanced colorectal cancer

Posted by on Nov 30, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the efficacy and safety of two drug regimens in patients with advanced colorectal cancer. Some background Cetuxima (Erbitux) prolongs survival of patients with metastatic (spread beyond the original location of the tumor) colorectal cancer. The effects of cetuximab in combination with chemotherapy regimens that...

Read More

Do different radiation doses lead to different side effects in prostate cancer?

Posted by on Nov 23, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine how radiotherapy influenced patient quality of life after treatment. Some background Radiotherapy is a common treatment used in prostate cancer. It targets a direct beam of radiation at the cancer site, minimizing damage to adjacent healthy cells. There are numerous types of radiotherapy, including...

Read More

New type of surgery improves survival without disease in colon cancer patients

New type of surgery improves survival without disease in colon cancer patients

Posted by on Nov 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the disease-free survival rates of patients who had a complete mesocolic excision with patients who had conventional surgery for treatment of colon cancer. Some background Patients with rectal cancer have higher survival rates than colon cancer patients. This is in part due to the type of surgery carried out. Many...

Read More